Skip to main content
TipRanks
Go Ultimate75% OFF

VistaGen Therapeutics (VTGN) Q3 2022 Earnings Report

1,155 Followers

VTGN Q3 2022 EPS Results

Actual EPS
-$1.50
Consensus EPS
-$2.18
Beat/Miss
Beat by +$0.67
One Year Ago EPS
-$2.10

VTGN Q3 2022 Revenue Results

Actual Revenue
$357.90K
Expected Revenue
$339.00K
Beat/Miss
Beat by +$18.90K
YoY Revenue Growth
+14.13%

Earnings Announcement Details

Quarter
Q3 2022
Date
02/10/2022
Time
After Close
Conference Call
Thursday, February 10, 2022
VTGN Upcoming Earnings

VistaGen Therapeutics's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

VTGN Earnings History

VTGN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272027 (Q3)-0.32--0.45――
Nov 13, 20262027 (Q2)-0.38-0.24-0.5455.56% (+0.30)
Aug 14, 20262027 (Q1)-0.36-0.30-0.4736.17% (+0.17)
Jun 15, 20262026 (Q4)-0.34-0.37-0.4313.95% (+0.06)
Feb 12, 20262026 (Q3)-0.49-0.45-0.462.17% (+0.01)
Nov 13, 20252026 (Q2)-0.48-0.54-0.42-28.57% (-0.12)
Aug 07, 20252026 (Q1)-0.47-0.47-0.35-34.29% (-0.12)
Jun 17, 20252025 (Q4)-0.50-0.430.3-243.33% (-0.73)
Feb 13, 20252025 (Q3)-0.51-0.46-0.22-109.09% (-0.24)
Nov 07, 20242025 (Q2)-0.39-0.42-0.6636.36% (+0.24)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed